Volume 1, Issue 1, Pages (February 2002)

Slides:



Advertisements
Similar presentations
2-Methoxyestradiol Inhibits Hypoxia-Inducible Factor-1α and Suppresses Growth of Lesions in a Mouse Model of Endometriosis  Christian M. Becker, Nadine.
Advertisements

C/EBPα inhibits hepatocellular carcinoma by reducing Notch3/Hes1/p27 cascades  Yi-Chao Shi, Hong Zhao, Chuan Yin, Xin Zeng, Qing Zhang, Wen-Ping Xu, Ji.
Darren M Brown, Erkki Ruoslahti  Cancer Cell 
Volume 129, Issue 4, Pages (October 2005)
Li Ding, Lingling Han, Yin Li, Jing Zhao, Ping He, Weizhen Zhang 
Endosialin (Tem1) Is a Marker of Tumor-Associated Myofibroblasts and Tumor Vessel- Associated Mural Cells  Sven Christian, Renate Winkler, Iris Helfrich,
PI3K as a Potential Therapeutic Target in Thymic Epithelial Tumors
Molecular Diagnosis of Epstein-Barr Virus-Related Diseases
Volume 61, Issue 2, Pages (February 2002)
Kuo-Jung Li, Ai-Li Shiau, Yuan-Yow Chiou, Yi-Te Yo, Chao-Liang Wu 
Self-Excising Retroviral Vectors Encoding the Cre Recombinase Overcome Cre- Mediated Cellular Toxicity  Daniel P. Silver, David M. Livingston  Molecular.
Volume 137, Issue 2, Pages e2 (August 2009)
The Rb-Related p130 Protein Controls Telomere Lengthening through an Interaction with a Rad50-Interacting Protein, RINT-1  Ling-Jie Kong, Alison R. Meloni,
Volume 10, Issue 2, Pages (August 2006)
Volume 136, Issue 5, Pages (May 2009)
Volume 71, Issue 3, Pages (February 2007)
Volume 13, Issue 6, Pages (November 2015)
Kathryn J. Moore, Takashi Wada, Susannah D. Barbee, Vicki Rubin Kelley 
Volume 138, Issue 2, Pages (February 2010)
Volume 134, Issue 1, Pages (January 2008)
Volume 15, Issue 2, Pages (February 2009)
Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions  Riichiro Abe, Tadamichi Shimizu, Hiroshi Sugawara, Hirokazu Watanabe,
Complexity of VEGF Responses in Skin Carcinogenesis Revealed through Ex Vivo Assays Based on a VEGF-A Null Mouse Keratinocyte Cell Line  Isabel Mirones,
Volume 22, Issue 4, Pages (April 2014)
Terminal Differentiation of Human Breast Cancer through PPARγ
Volume 127, Issue 1, Pages (July 2004)
Volume 132, Issue 7, Pages (June 2007)
Volume 3, Issue 1, Pages (January 2003)
Shalmali J. Dharma, M. Sc. , Deepak N. Modi, Ph. D. , Tarala D
PIAS1 Promotes Lymphomagenesis through MYC Upregulation
Volume 7, Issue 2, Pages (February 2010)
Volume 2, Issue 2, Pages (February 2008)
Volume 37, Issue 4, Pages (October 2012)
Volume 117, Issue 7, Pages (June 2004)
Volume 97, Issue 4, Pages (May 1999)
Darren M Brown, Erkki Ruoslahti  Cancer Cell 
Reversible Tumorigenesis by MYC in Hematopoietic Lineages
Jungmook Lyu, Vicky Yamamoto, Wange Lu  Developmental Cell 
Volume 19, Issue 6, Pages (June 2011)
14-3-3σ Regulates Keratinocyte Proliferation and Differentiation by Modulating Yap1 Cellular Localization  Sumitha A.T. Sambandam, Ramesh B. Kasetti,
Noritaka Oyama, Keiji Iwatsuki, Yoshimi Homma, Fumio Kaneko 
Anke Sparmann, Dafna Bar-Sagi  Cancer Cell 
Incorporation of the B18R Gene of Vaccinia Virus Into an Oncolytic Herpes Simplex Virus Improves Antitumor Activity  Xinping Fu, Armando Rivera, Lihua.
Volume 14, Issue 5, Pages (November 2011)
Volume 22, Issue 3, Pages (September 2012)
Multiple Functions of the 37/67-kd Laminin Receptor Make It a Suitable Target for Novel Cancer Gene Therapy  Jonathan Scheiman, Jen-Chieh Tseng, Yun Zheng,
Volume 8, Issue 6, Pages (December 2010)
Volume 2, Issue 3, Pages (September 2002)
Volume 6, Issue 1, Pages (July 2009)
Hepsin promotes prostate cancer progression and metastasis
Volume 17, Issue 23, Pages (December 2007)
Volume 13, Issue 4, Pages (April 2008)
Jaana Mannik, Kamil Alzayady, Soosan Ghazizadeh 
Volume 21, Issue 1, Pages (January 2013)
Volume 26, Issue 1, Pages (January 2018)
Volume 10, Issue 6, Pages (December 2004)
Loss of Keratin 10 Leads to Mitogen-activated Protein Kinase (MAPK) Activation, Increased Keratinocyte Turnover, and Decreased Tumor Formation in Mice 
Volume 13, Issue 6, Pages (November 2015)
Molecular Therapy - Oncolytics
Volume 125, Issue 7, Pages (June 2006)
The effect of the selective cyclooxygenase-2 inhibitor rofecoxib on human colorectal cancer liver metastases  Stephen W. Fenwick, Giles J. Toogood, J.Peter.
Kristiina Airola, Norbert E. Fusenig 
Single-Shot, Multicycle Suicide Gene Therapy by Replication-Competent Retrovirus Vectors Achieves Long-Term Survival Benefit in Experimental Glioma  Chien-Kuo.
Volume 4, Issue 4, Pages (October 1999)
Volume 19, Issue 5, Pages (May 2011)
Volume 6, Issue 2, Pages (August 2004)
Kathryn J. Moore, Takashi Wada, Susannah D. Barbee, Vicki Rubin Kelley 
Volume 118, Issue 3, Pages (March 2000)
Volume 12, Issue 5, Pages (November 2005)
Matrix Metalloproteinase Inhibitor BB-3103 Unlike the Serine Proteinase Inhibitor Aprotinin Abrogates Epidermal Healing of Human Skin Wounds Ex Vivo1 
Presentation transcript:

Volume 1, Issue 1, Pages 53-62 (February 2002) Induction of ovarian cancer by defined multiple genetic changes in a mouse model system  Sandra Orsulic, Yi Li, Robert A. Soslow, Lynn A. Vitale-Cross, J.Silvio Gutkind, Harold E. Varmus  Cancer Cell  Volume 1, Issue 1, Pages 53-62 (February 2002) DOI: 10.1016/S1535-6108(01)00002-2

Figure 1 Strategy for viral gene delivery to ovarian cells in vitro and introduction of infected cells into recipient mice Ovaries are isolated from a TVA transgenic mouse to restrict infection to ovarian cells. DF-1 chicken cells transfected with an RCAS vector carrying a gene of interest are used to obtain high titer virus stock. In vitro propagation of primary ovarian cells facilitates multiple rounds of infection with a combination of RCAS viruses carrying different oncogenes and marker genes. After several days of infection in vitro, ovarian cells are aggregated and implanted into recipient mice. Cancer Cell 2002 1, 53-62DOI: (10.1016/S1535-6108(01)00002-2)

Figure 2 Expression of TVA and susceptibility of ovarian cells from TVA transgenic mice to RCAS infection A: Immunohistochemical detection of the TVA receptor with the TVA antibody. Ovaries isolated from β-actin-TVA transgenic mice express the TVA receptor in both stromal cells and the ovarian surface epithelium. In ovaries isolated from keratin 5-TVA transgenic mice, expression of the TVA receptor is restricted to the cells of the ovarian surface epithelium. B: Detection of RCAS-AP-infected cells by AP color reaction. Ovarian cells from each transgenic line were infected with the RCAS-AP virus in culture. Endogenous AP was heat-inactivated, and the infected cells that produce AP were detected by the AP color reaction. Both stromal and epithelial cells from β-actin-TVA ovaries are susceptible to RCAS-AP infection. In ovaries from keratin 5-TVA mice, only the ovarian surface epithelial cells are susceptible to RCAS-AP infection, while stromal cells are AP-negative. Cancer Cell 2002 1, 53-62DOI: (10.1016/S1535-6108(01)00002-2)

Figure 3 Expression of oncogenic proteins in ovarian cells after in vitro infection with RCAS viruses Western blot of β-actin-TVA/p53−/− ovarian cells infected with RCAS viruses carrying AP, c-myc, K-ras, or Akt, individually or in combinations of two RCAS viruses. The same amount of cell lysate was loaded into each lane. HA-tagged Akt and K-ras proteins were detected with the anti-HA probe. The expression of c-myc was determined with an antibody against human c-myc. Cancer Cell 2002 1, 53-62DOI: (10.1016/S1535-6108(01)00002-2)

Figure 4 Oncogenic c-myc and K-ras collaborate in inducing proliferation of epithelial ovarian cells A: Proliferation curves of ovarian cells from βactin-TVA/p53−/− mice that were infected with RCAS viruses carrying AP, c-myc, K-ras, or with a combination of RCAS viruses carrying c-myc and K-ras. Five days after infection with RCAS viruses, each culture of the virally infected cells was split into 12 separate cultures that were maintained for 8 days. The cell proliferation rates were determined by fixing triplicate cultures every 2 days, staining them with crystal violet dye, and measuring the light absorbance of the extracted dye at 590 nm. This procedure allowed us to count the proliferating cells, as well as the viable terminally differentiated cells that would normally be lost if the cells were continually passaged. Proliferation curves were plotted as a ratio of the light absorbance and the time. The error bars indicate the extreme values of light absorbance in three separate cultures. Proliferation of ovarian cells from β-actin-TVA/p53−/− mice was induced by oncogenic change in either c-myc or K-ras, but the effect was further amplified in ovarian cells with genetic changes in both genes. B: Morphological appearance of the cell populations described in A at day 6. Cultured ovarian cells infected with RCAS-AP acquire features of normal terminal differentiation and senes-cence. Introduction of oncogenic lesions induces marked changes to ovarian cell mor-phology and differentiation, which is especially pronounced in the ovarian epithelial cells. C: Representative cross-sections of ovarian cell populations in B. Cancer Cell 2002 1, 53-62DOI: (10.1016/S1535-6108(01)00002-2)

Figure 5 Ovarian surface epithelium is the precursor tissue for ovarian carcinoma A–C: Sections of a subcutaneous tumor in a nude mouse derived from the keratin 5-TVA/p53−/− ovarian cells infected with a combination of RCAS-c-myc and RCAS-Akt viruses. The consecutive sections were probed with antibodies that recognize TVA, Keratin 8 and the HA-tagged Akt protein. Insets show a normal ovary from an uninfected keratin 5-TVA mouse probed with the same antibodies. A: The TVA-positive cells in the tumor originate from the ovarian surface epithelium because this is the only cell type that expresses TVA in the ovaries from keratin 5-TVA transgenic mice (A, inset). B: The same TVA-positive cells in the tumor are also positive for the Keratin 8 marker, indicating that they maintain their epithelial characteristics and resemble the Keratin 8-positive cells of the ovarian surface epithelium (B, inset). C: The TVA-positive cells in the tumor also express virally introduced Akt oncogene. The HA-tagged Akt is not present in the uninfected ovary (C, inset). D and E: Consecutive sections of a subcutaneous tumor in a nude mouse derived from the β-actin-TVA/p53−/− ovarian cells infected with a combination of RCAS-c-myc and RCAS-K-ras viruses. The sections were probed with antibodies that recognize TVA receptor and Keratin 8. Insets show a normal ovary from uninfected β-actin-TVA mouse probed with the same antibodies as the tumor sections. D: The tumor consists of TVApositive and TVA-negative cells. The TVA-positive cells originate from the ovary of the β-actin-TVA transgenic mouse (D, inset). Since all cells from β-actin-TVA ovaries express TVA, the TVA-negative stromal cells in the tumor must be recruited from the host tissue and not from ovarian stroma. E: The TVA-positive cells in the tumor are epithelial as determined by the expression of the Keratin 8 marker which is present exclusively in the epithelial cells in the ovary (E, inset). Each bar represents 50 μm. Cancer Cell 2002 1, 53-62DOI: (10.1016/S1535-6108(01)00002-2)

Figure 6 Intraperitoneal tumor spread in nude mice after implantation of ovarian cells with induced genetic lesions under the ovarian bursa A–E: Tumors derived from β-actin-TVA/p53−/− ovarian cells that were infected with a combination of RCAS viruses carrying c-myc and K-ras oncogenes and implanted under the ovarian bursa of a nude mouse. A: Abdominal bloating and the presence of bloody ascites were the typical signs of the intraperitoneal tumor spread. B: Ovarian tumor spread in the peritoneal cavity. C: Ovarian tumor spread to the intraperitoneal and retroperitoneal organs. Arrows indicate ovarian tumor spread to the spleen, liver, intestine, kidney, and the contralateral ovary. D: Sections of the liver and the spleen probed with antibody against TVA to identify the ovarian tumor cell metastases. The tumor cells metastasize to the surfaces of organs (arrows) and deep into the tissue (arrowheads). E: Papillary organization of metastatic ovarian tumor resembles ovarian papillary carcinoma. Cancer Cell 2002 1, 53-62DOI: (10.1016/S1535-6108(01)00002-2)

Figure 7 Ovarian tumor induction in immunocompetent mice A: Ovarian cells from the right ovary of the β-actin-TVA/p53−/− mouse were transduced with c-myc, K-ras, and Akt oncogenes and implanted under the ovarian bursa of the left ovary. The arrow points to the tumor that developed in the left ovary three months after intrabursal implantation of the RCAS-infected ovarian cells. B: H&E staining of the tumor section reveals an undifferentiated epithelial neoplasm, arranged in nests. Cancer Cell 2002 1, 53-62DOI: (10.1016/S1535-6108(01)00002-2)